Fundraising Fox
/Companies
Sign in

Diabetomics

Hillsboro, US · 1 known investors

Find your way into Diabetomics

Sign up to see every warm intro you have to Diabetomics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Diabetomics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

ModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders. The company also supports pharmaceutical firms in drug development and therapeutic efficacy assessment.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

SR
Srinivasa Rao NagallaFounder
DG
Dave GundersonExecutive

Board

RM
Rick MillerBoard director
CD
Chris DudleyBoard director
RG
Robert GreggBoard director
RG
Robert GooteeBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$2.5M disclosed across 1 round · 2014

▶$2.5MraisedNov 2014 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dave GundersonExecutive Officer, Director
  • Rick MillerDirector
  • Chris DudleyDirector
  • Robert GreggDirector
  • Robert GooteeDirector
  • Srinivasa Rao NagallaExecutive Officer, Director, Promoter
Offering amount
$15M
Amount sold
$2.5M
First sale
Oct 2014
Incorporated
Corporation, Oregon
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Diabetomics do?
ModalityDx develops quantitative point-of-care diagnostic tests using molecular biomarkers and data science to detect and assess treatment response for diseases including diabetes, maternal health conditions, and autoimmune disorders. The company also supports pharmaceutical firms in drug development and therapeutic efficacy assessment.
Who founded Diabetomics?
Diabetomics was founded by Srinivasa Rao Nagalla.
Who are Diabetomics's investors?
Diabetomics's investors include VenturEast.
How much funding has Diabetomics raised?
Diabetomics has disclosed $2.5M raised across 1 round.
Where is Diabetomics headquartered?
Diabetomics is headquartered in Hillsboro, US.